Law360, New York (March 10, 2014, 7:22 PM EDT) -- Bowing to widespread outcry, federal regulators on Monday abandoned several controversial Medicare Part D proposals, including plans to end guaranteed access to certain drugs and cap the number of prescription drug plans that insurance companies offer.
The decision by the Centers for Medicare and Medicaid Services came on the heels of Friday's deadline to weigh in on the proposal. At least 7,500 comments were submitted — about 15 times the number received during the most recent prior round of Part D tweaks — with a large number appearing hostile to CMS' plans.
"During the rule's comment period, we received numerous concerns...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!